Detalhe da pesquisa
1.
Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo.
J Biol Chem
; 286(43): 37077-84, 2011 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900253
2.
Carotid intima-media thickness and plaque assessment by trained medical residents: validation and preliminary testing of a training protocol.
J Am Soc Echocardiogr
; 26(12): 1457-64, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24050846
3.
Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system.
J Immunol
; 177(6): 3582-9, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16951317
4.
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.
Int J Cancer
; 114(2): 268-73, 2005 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15540228
5.
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Cancer
; 103(12): 2517-25, 2005 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15880379